Replies to post #80479 on Biotech Values

[Lungman424]

i think bapineuzimab has at least a 25% shot. But I do think it may no longer be the frontrunner...

I think you might be right, what I don't understand is than why would you think getting 1B+ for a 1 in 4 shot while still retaining 50% of what you had before, is such a "bad" deal, especially when you feel that it would be even less than a 25% shot it ELN was still running the show and with your feeling it's no longer even the frontrunner...